Key Developments: IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

147.98USD
18 Dec 2014
Price Change (% chg)

$3.48 (+2.41%)
Prev Close
$144.50
Open
$146.11
Day's High
$148.01
Day's Low
$144.74
Volume
90,994
Avg. Vol
200,976
52-wk High
$153.48
52-wk Low
$103.19

Search Stocks

Latest Key Developments (Source: Significant Developments)

IDEXX Laboratories Inc lowers FY 2014 revenue guidance; raises FY 2014 EPS guidance; gives FY 2015 guidance above analysts' estimates
Friday, 24 Oct 2014 07:04am EDT 

IDEXX Laboratories Inc:Updates its organic revenue growth guidance for FY 2014 to 9.5 pct. to reflect growth trends at high end of its previous guidance range.Expects FY 2014 adjusted revenue in the range of $1.505 - $1.510 billion.Favorable operating performance, reduced tax expense, and reduction in outstanding shares are partially offset by unfavorable impacts of foreign exchange, resulting in an increase from its previous adjusted EPS guidance of $3.79 to $3.86 to its current adjusted EPS guidance of $3.85 to $3.90.Expects FY 2015 revenue in the range of $1.690 - $1.710 billion.Expects FY 2015 EPS in the range of $4.38 - $4.48.FY 2014 revenue of $1.504 billion and EPS of $3.82 - Thomson Reuters I/B/E/S.FY 2015 revenue of $1.654 billion and EPS of $4.33 - Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc raises FY 2014 revenue outlook; reaffirms FY 2014 EPS outlook
Friday, 25 Jul 2014 07:01am EDT 

IDEXX Laboratories Inc:Expects FY 2014 revenue in the range of $1,510 - $1,520 mln.Expects FY 2014 adjusted EPS in the range of $3.79 - $3.86.FY 2014 revenue of $1.496 bln, EPS of $3.84 - Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc reaffirms FY 2014 EPS outlook
Friday, 25 Apr 2014 07:02am EDT 

IDEXX Laboratories Inc:Expects FY 2014 EPS in the range of $3.76-$3.86.Expects FY 2014 Non-GAAP EPS in the range of $3.76-$3.86.FY 2014 EPS of $3.83 - Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc issues FY 2014 guidance in line with analysts' estimates
Tuesday, 4 Feb 2014 07:00am EST 

IDEXX Laboratories Inc:Sees fiscal 2014 revenues to be in the range of $1.48 billion to $1.50 billion.Sees fiscal 2014 EPS to be in the range of $3.76 to $3.86.Fiscal 2014 revenue of $1.48 billion - Thomson Reuters I/B/E/S.Fiscal 2014 EPS of $3.84 - Thomson Reuters I/B/E/S.  Full Article

IDEXX Laboratories Inc updates on FY 2013 revenue guidance - Conference Call
Monday, 13 Jan 2014 06:30am EST 

IDEXX Laboratories Inc:Sees FY 2013 organic revenue growth of 7 pct to 8 pct organic revenue growth.  Full Article

IDEXX Laboratories Inc Names Brian McKeon Executive Vice President And Chief Financial Officer
Tuesday, 15 Oct 2013 09:30am EDT 

IDEXX Laboratories, Inc announced that the appointment of Brian McKeon to serve as the Company's Executive Vice President and Chief Financial Officer, effective January 1, 2014. As Chief Financial Officer, McKeon will be a member of the Company's senior executive leadership team and will have oversight of the finance and information technology functions. McKeon will report to Jonathan Ayers, Chairman, President and Chief Executive Officer of the Company.  Full Article

IDEXX Laboratories Inc Acquires Brazil Distributor
Wednesday, 21 Aug 2013 07:00am EDT 

IDEXX Laboratories, Inc. announced that it has acquired all outstanding shares of Madasa do Brasil Ltda. (Madasa). Based in Sao Paulo, Brazil, Madasa is a distributor of IDEXX Dairy and bovine testing products, as well as other food safety testing products.  Full Article

IDEXX Laboratories Inc Lowers FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance-Conference Call
Thursday, 25 Jul 2013 12:00pm EDT 

IDEXX Laboratories Inc announced that revenues for fiscal 2013 expected to be $1.37 billion to $1.38 billion reflecting expected full year organic revenue growth of 7.0% to 7.5%, down from previous guidance of 7.5% to 8.0% due to organic revenue growth in the second quarter and an anticipated reduction in capital equipment sales relative to previous expectations. Reported revenue growth is projected at 6.0% to 6.5% which is down from our previous guidance of 7.0% to 7.5% due to the reduction in expected full year organic revenue growth and unfavorable changes in foreign currency exchange rates. EPS is expected to be $3.42 to $3.48 compared to previous guidance of $3.40 to $3.46. The increase in EPS from previous guidance is due to revised share count estimates reflecting our latest assumptions on share repurchase. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.37 billion and EPS of $3.46 for fiscal 2013.  Full Article

IDEXX Laboratories Inc Lowers FY 2013 EPS Guidance-Conference Call
Tuesday, 11 Jun 2013 10:30am EDT 

IDEXX Laboratories Inc announced that for fiscal 2013, it expects earnings guidance to be $3.40 to $3.46. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.44 for fiscal 2013.  Full Article

IDEXX Laboratories Inc Lowers FY 2013 Guidance
Tuesday, 23 Apr 2013 07:00am EDT 

IDEXX Laboratories Inc announced that for fiscal 2013, it expects revenues to be $1.38 billion to $1.39 billion, organic growth is estimated to be in the range of 7.5% to 8%, as compared with previous guidance of 8% to 9%, reflective of organic growth in the first quarter and an anticipated reduction in capital equipment sales in ensuing quarters from previous guidance. The decrease in expected reported revenue is the result of unfavorable changes in foreign currency exchange rates, reflecting a strengthening of the U.S. dollar relative to other currencies since the date of previous guidance, as well as the reduction in outlook for 2013 organic growth. EPS are expected to be $3.40 to $3.46 on a GAAP and non-GAAP basis. This compares to previous guidance which reflected EPS of $3.47 to $3.57 on a GAAP basis and $3.42 to $3.52 on a non-GAAP basis. EPS on a non-GAAP basis are adjusted to exclude the favorable impact of the retroactive extension of the 2012 federal R&D tax credit and the unfavorable impact of the third-party service provider's bankruptcy. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.401 billion and EPS of $3.54 for fiscal 2013.  Full Article

Search Stocks